<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-040568</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Type 1 Gaucher disease: 10 years of experience in enzyme replacement therapy</dc:title>
<dc:description xml:lang="en">Gaucher disease is an inherited Iysosomal storage disorder caused by a defect in the gene encoding the enzyme acid 13glucosidase. This deficiency causes the accumulation of glucocerebrosides in the Iysosomes of visceral macrophages, leading to the clinical manifestations of this disease.    The most prevalent form of Gaucher disease is type 1 or the non-neuronopathic variant, which is characterized by clinical features such as hepatosplenomegaly, anemia, thrombocytopenia and bone disease. The prognosis associated with this disorder was especially poor when the only available therapeutic options were splenectomy and bone marrow transplantation. Gaucher disease was the first Iysosomal storage disorder in which enzyme replacement therapy was employed. Over the last decade, this treatment has proven both safe and highly efficacious, leading to an improvement in the quality of life of patients and a decreased morbidity and mortality.    We report the satisfactory clinical courses of four patients, two of them treated since 1995, after undergoing enzyme replacement therapy. Three of these patients have normal clinical, radiological and hematological parameters. In the fourth patient. who presents a concomitant hemoglobinopathy, the need for red cell transfusions has decreased. None of these patients have experienced adverse events related to enzyme replacement therapy</dc:description>
<dc:creator>Dalmau Serra, J</dc:creator>
<dc:creator>Escrig Fernández, R</dc:creator>
<dc:creator>Alentado Morell, N</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La enfermedad de Gaucher es una enfermedad lisosomal hereditaria, consecuencia de un defecto en el gen que codifica la enzima betaglucosidasa ácida, cuya deficiencia condiciona la acumulación de glucocerebrósidos en los lisosomas de los macrófagos, causando las manifestaciones clínicas de la enfermedad.    La forma más frecuente es el tipo I o no neuronopática, caracterizada por la presencia de visceromegalias, alteraciones hematológicas y cambios óseos estructurales. Se caracteriza por su mal pronóstico, especialmente cuando sólo se disponía de esplenectomía y trasplante de medula ósea como únicas posibilidades terapéuticas. Es la primera enfermedad de depósito en que se ha utilizado la terapia enzimática sustitutiva, que ha demostrado su seguridad y eficacia durante la última década, permitiendo mejorar la calidad de vida de los pacientes y disminuir su morbimortalidad.    Presentamos la evolución clínica satisfactoria de cuatro pacientes, con normalización de parámetros clínicos, analíticos y radiológicos en los tres primeros, y con disminución de la frecuencia de transfusiones en la paciente con hemoglobinopatía concomitante. Nihguno de los individuos ha padecido ninguna complicación atribuible a la terapia enzimática sustitutiva</dc:description>
<dc:source>Acta Pediatr Esp;63(9): 373-376, oct. 2005. tab</dc:source>
<dc:identifier>ibc-040568</dc:identifier>
<dc:title xml:lang="es">Enfermedad de Gaucher tipo 1: 10 años de experiencia en el tratamiento enzimático sustitutivo</dc:title>
<dc:subject>^d5916^s22012</dc:subject>
<dc:subject>^d13546^s22053</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d22190^s22078</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d5916^s22053</dc:subject>
<dc:subject>^d22190^s22000</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d8836^s22033</dc:subject>
<dc:subject>^d30000^s22054</dc:subject>
<dc:subject>^d30000^s22053</dc:subject>
<dc:subject>^d13546^s22027</dc:subject>
<dc:subject>^d30000^s22012</dc:subject>
<dc:subject>^d5916^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>200510</dc:date>
</metadata>
</record>
</ibecs-document>
